Geneva, Jan. 12 -- International Clinical Trials Registry received information related to the study (ChiCTR2500114837) titled 'Research on the Efficacy and Mechanisms of a GLP-1 Probiotic Formulation in Improving Overweight/Obesity and Related Complications' on Dec. 18, 2025.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: Reproductive Hospital Affiliated to Jiangxi University of Traditional Chinese Medicine
Condition:
Overweight/Obesity
Intervention:
Normal healthy group:None
Placebo group :Placebo
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2025-12-20
Target Sample Size: Normal healthy group:50;Placebo group :50;GLP-1 Probiotic group:100;
Countries of Recruitment:
Chi...